Breast cancer is the most common cancer among women worldwide, which is a disease in which breast cells grow out of control. Breast cancer is the second leading cause of cancer […]
The latest research shows that the new small molecule compound Me6TREN can promote the regeneration of intestinal stem cells after radiation, and is expected to become a candidate drug for the […]
Lilly recently announced that its RET inhibitor, selpercatinib (loxo-292), has been granted priority review status by the U.S. FDA and is expected to accelerate its approval for the treatment of […]
Ras has been described to promote proliferation, suppress apoptosis, alter cell metabolism, disrupt morphogenesis, promote evasion of the immune system, induce remodeling of the microenvironment and stimulate metastasis. These functions are […]